litlas
ログインアカウント作成

Christopher P. Austin

1962–2024 年に発表

138
論文数
28,098
被引用数
92
h 指数
136
i10 指数

被引用数

Christopher P. Austin の年別被引用数1900 年: 被引用 1 件1963 年: 被引用 1 件1965 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 1 件1981 年: 被引用 2 件1985 年: 被引用 1 件1987 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 4 件1992 年: 被引用 10 件1993 年: 被引用 16 件1994 年: 被引用 16 件1995 年: 被引用 17 件1996 年: 被引用 28 件1997 年: 被引用 48 件1998 年: 被引用 34 件1999 年: 被引用 55 件2000 年: 被引用 94 件2001 年: 被引用 161 件2002 年: 被引用 128 件2003 年: 被引用 164 件2004 年: 被引用 167 件2005 年: 被引用 165 件2006 年: 被引用 163 件2007 年: 被引用 162 件2008 年: 被引用 221 件2009 年: 被引用 280 件2010 年: 被引用 289 件2011 年: 被引用 283 件2012 年: 被引用 322 件2013 年: 被引用 296 件2014 年: 被引用 284 件2015 年: 被引用 297 件2016 年: 被引用 383 件2017 年: 被引用 295 件2018 年: 被引用 327 件2019 年: 被引用 799 件2020 年: 被引用 855 件2021 年: 被引用 941 件2022 年: 被引用 800 件2023 年: 被引用 593 件2024 年: 被引用 777 件2025 年: 被引用 377 件2026 年: 被引用 29 件1901〜1962 年は被引用が無いため表示していません1964 年は被引用が無いため表示していません1966〜1978 年は被引用が無いため表示していません1982〜1984 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,213 件、この内訳の 33.5%イギリス: 引用元論文 974 件、この内訳の 7.7%中国: 引用元論文 896 件、この内訳の 7.1%ドイツ: 引用元論文 752 件、この内訳の 6%カナダ: 引用元論文 474 件、この内訳の 3.8%イタリア: 引用元論文 399 件、この内訳の 3.2%日本: 引用元論文 395 件、この内訳の 3.1%フランス: 引用元論文 384 件、この内訳の 3.1%オランダ: 引用元論文 302 件、この内訳の 2.4%オーストラリア: 引用元論文 287 件、この内訳の 2.3%スペイン: 引用元論文 272 件、この内訳の 2.2%スイス: 引用元論文 269 件、この内訳の 2.1%
0%33.5%その他 23.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology36.5%
  • Medicine24.9%
  • Computer Science14.3%
  • Neuroscience7.4%
  • Engineering3.8%
  • Immunology and Microbiology2.7%
  • その他10.4%

トピック

  • Computational Drug Discovery Methods6.6%
  • Retinal Development and Disorders2.2%
  • 3D Printing in Biomedical Research1.5%
  • Cancer, Hypoxia, and Metabolism1.4%
  • Receptor Mechanisms and Signaling1.2%
  • Bioinformatics and Genomic Networks1.1%
  • その他86%

共著者

全論文

検索で開く
  1. Organs-on-chips: into the next decade

    著者: Lucie A. Low, Christine L. Mummery, Brian R. Berridge, Christopher P. Austin, Danilo A. Tagle - Nature Reviews Drug Discovery 2020 被引用: 928

  2. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment

    著者: Melissa A. Haendel, Christopher G. Chute, Tellen D. Bennett, David A. Eichmann, Justin Guinney, Warren A. Kibbe, Philip R. O. Payne, Emily R. Pfaff, Peter N. Robinson, Joel H. Saltz, Heidi Spratt, Christine Suver, John Wilbanks, Adam B. Wilcox, Andrew E. Williams, Chunlei Wu, Clair Blacketer, Robert L. Bradford, James J. Cimino, Marshall Clark, Evan W. Colmenares, Patricia A. Francis, Davera Gabriel, Alexis Graves, Raju Hemadri, Stephanie S. Hong, George Hripcsak, Dazhi Jiao, Jeffrey G. Klann, Kristin Kostka, Adam M. Lee, Harold P. Lehmann, Lora Lingrey, Robert T. Miller, Michele Morris, Shawn N. Murphy, Karthik Natarajan, Matvey B. Palchuk, Usman Sheikh, Harold Solbrig, Shyam Visweswaran, Anita Walden, Kellie M. Walters, Griffin M. Weber, Xiaohan Tanner Zhang, Richard L. Zhu, Benjamin R. C. Amor, Andrew T. Girvin, Amin Manna, Nabeel Qureshi, Michael G. Kurilla, Sam G. Michael, Lili M. Portilla, Joni L. Rutter, Christopher P. Austin, Kenneth R. Gersing - Journal of the American Medical Informatics Association, J. Am. Medical Informatics Assoc. 2020 被引用: 588

  3. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

    著者: Dimitrios Anastasiou, Yimin Yu, William J. Israelsen, Jian‐kang Jiang, Matthew B. Boxer, Bum Soo Hong, W. Tempel, Svetoslav Dimov, Min Shen, Abhishek Jha, Hua Yang, Katherine Mattaini, Christian M. Metallo, Brian P. Fiske, Kevin D. Courtney, Scott Malstrom, Tahsin Khan, Charles Kung, Amanda P. Skoumbourdis, Henrike Veith, Noel Southall, Martin J. Walsh, Kyle R. Brimacombe, William Leister, Sophia Y. Lunt, Zachary Johnson, Katharine Yen, Kaiko Kunii, Shawn M. Davidson, Heather R. Christofk, Christopher P. Austin, James Inglese, Marian H. Harris, John M. Asara, Gregory Stephanopoulos, Francesco G. Salituro, Shengfang Jin, Lenny Dang, Douglas S. Auld, Hee‐Won Park, Lewis C. Cantley, Craig J. Thomas, Matthew G. Vander Heiden - Nature Chemical Biology 2012 被引用: 825

  4. The Tox21 10K Compound Library: Collaborative Chemistry Advancing Toxicology

    著者: Ann M. Richard, Ruili Huang, Suramya Waidyanatha, Paul Shinn, Bradley J. Collins, Inthirany Thillainadarajah, Chris Grulke, Antony Williams, Ryan Lougee, Richard Judson, Keith A. Houck, Mahmoud Shobair, Chihae Yang, James F. Rathman, Adam Yasgar, Suzanne Fitzpatrick, Anton Simeonov, Russell S. Thomas, Kevin M. Crofton, Richard S. Paules, John R. Bucher, Christopher P. Austin, Robert J. Kavlock, Raymond R. Tice - Chemical Research in Toxicology 2020 被引用: 310

  5. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

    著者: Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay E. Davies, Stephen C. Groft, Robert A. Preti, Tudor I. Oprea, Marco Prunotto - Nature Reviews Drug Discovery 2019 被引用: 351

  6. The promise and peril of chemical probes

    著者: C.H. Arrowsmith, James E. Audia, Christopher P. Austin, Jonathan B. Baell, Jonathan P. Bennett, Julian Blagg, C. Bountra, Paul E. Brennan, Peter J. Brown, Mark E. Bunnage, Carolyn Buser‐Doepner, Robert M Campbell, Adrian J. Carter, Philip Cohen, Robert A. Copeland, Ben Cravatt, Jayme L. Dahlin, Dashyant Dhanak, A.M. Edwards, Mathias Frederiksen, Stephen V. Frye, Nathanael S. Gray, Charles E. Grimshaw, David Hepworth, Trevor Howe, K. Huber, Jian Jin, Stefan Knapp, Joanne Kotz, Ryan G. Kruger, Derek Lowe, Mary M. Mader, Brian D. Marsden, Anke Mueller‐Fahrnow, Susanne Müller, Rónán C. O’Hagan, John P. Overington, Dafydd R. Owen, Saul H. Rosenberg, Ruth A. Ross, Bryan L. Roth, Matthieu Schapira, Stuart L. Schreiber, Brian K. Shoichet, M. Sundström, Giulio Superti-Furga, Jack Taunton, Leticia Toledo‐Sherman, Chris Walpole, Michael A. Walters, Timothy M. Willson, Paul Workman, Robert N. Young, William J. Zuercher - Nature Chemical Biology 2015 被引用: 850

  7. The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics

    著者: Ruili Huang, Ivan Grishagin, Yuhong Wang, Tongan Zhao, Jon Greene, John C. Obenauer, Deborah K. Ngan, Ðắc-Trung Nguyễn, Rajarshi Guha, Ajit Jadhav, Noel Southall, Anton Simeonov, Christopher P. Austin - Frontiers in Pharmacology 2019 被引用: 320

  8. Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

    著者: Christopher P. Austin, Christine M. Cutillo, Lilian Pek Lian Lau, Anneliene Hechtelt Jonker, Ana Rath, Daria Julkowska, David Thomson, Sharon F. Terry, Béatrice de Montleau, Diego Ardigò, Virginie Hivert, Kym M. Boycott, Gareth Baynam, Petra Kaufmann, Domenica Taruscio, Hanns Lochmüller, Makoto Suematsu, Carlo Incerti, Ruxandra Draghia‐Akli, Iréne Norstedt, Lu Wang, Hugh Dawkins - Clinical and Translational Science 2017 被引用: 249

  9. Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries

    著者: James Inglese, Douglas S. Auld, Ajit Jadhav, Ronald L. Johnson, Anton Simeonov, Adam Yasgar, Wei Zheng, Christopher P. Austin - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 820

  10. Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries

    著者: Henrike Veith, Noel Southall, Ruili Huang, Tim James, Darren Fayne, Natalia V. Artemenko, Min Shen, James Inglese, Christopher P. Austin, David G. Lloyd, Douglas S. Auld - Nature Biotechnology 2009 被引用: 219

  11. A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells

    著者: Yu Chen, Carlos A. Tristan, Lu Chen, Vukasin M. Jovanovic, Claire Malley, Pei‐Hsuan Chu, Seungmi Ryu, Tao Deng, Pinar Ormanoglu, Dingyin Tao, Yuhong Fang, Jaroslav Slamecka, Hyenjong Hong, Christopher A. LeClair, Sam Michael, Christopher P. Austin, Anton Simeonov, Ilyas Singeç - Nature Methods 2021 被引用: 186

  12. Improving the Human Hazard Characterization of Chemicals: A Tox21 Update

    著者: Raymond R. Tice, Christopher P. Austin, Robert J. Kavlock, John R. Bucher - Environmental Health Perspectives 2013 被引用: 612

  13. Opportunities and challenges in translational science

    著者: Christopher P. Austin - Clinical and Translational Science 2021 被引用: 167

  14. Assay Guidance Manual [Internet]

    著者: Sarine Markossian, A Grossman, Kyle R. Brimacombe, Michelle R. Arkin, Douglas S. Auld, Christopher P. Austin, Jonathan B. Baell, Thomas D.Y. Chung, Nathan P. Coussens, Jayme L. Dahlin, Viswanath Devanarayan, Timothy L. Foley, Marcie A. Glicksman, Matthew D. Hall, Joseph V. Haas, Sam R.J. Hoare, James Inglese, Philip W. Iversen, Stephen C. Kales, Madhu Lal‐Nag, Zhuyin Li, J McGee, Owen B. McManus, Terry Riss, P Saradjian, G. Sitta Sittampalam, Mike Tarselli, O. Joseph Trask, Yueming Wang, Jeffrey R. Weidner, Mary Jo Wildey, Kelli M. Wilson, Menghang Xia, Xin Xu - 2004 被引用: 287

  15. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

    著者: Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, Benjamin Amor, Adit Anand, Mark M. Bissell, Katie R. Bradwell, Carolyn Bremer, James Brian Byrd, Alina Denham, Peter E. DeWitt, Davera Gabriel, Brian T. Garibaldi, Andrew T. Girvin, Justin Guinney, Elaine Hill, Stephanie Hong, Hunter Jimenez, Ramakanth Kavuluru, Kristin Kostka, Harold P. Lehmann, Eli Levitt, Sandeep K. Mallipattu, Amin Manna, Julie A. McMurry, Michele Morris, John Muschelli, Andrew J. Neumann, Matvey B. Palchuk, Emily Pfaff, Zhenglong Qian, Nabeel Qureshi, Seth Russell, Heidi Spratt, Anita Walden, Andrew E. Williams, Jacob T. Wooldridge, Yun Jae Yoo, Xiaohan Tanner Zhang, Richard L. Zhu, Christopher P. Austin, Joel Saltz, Kenneth Gersing, Melissa Haendel, Christopher G. Chute, Joel Gagnier, Siqing Hu, Kanchan Lota, Sarah E. Maidlow, David A. Hanauer, Kevin J. Weatherwax, Nikhila Gandrakota, Rishikesan Kamaleswaran, Greg S. Martin, Jingjing Qian, Jason E. Farley, Patricia A. Francis, Dazhi Jiao, Hadi Kharrazi, Justin Reese, Mariam Deacy, Usman Ullah Sheikh, Jake Y. Chen, Michael Quinn Patton, T. Bennett Ramsey, Jasvinder A. Singh, James J. Cimino, Jing Su, William G. Adams, Timothy Q. Duong, John B. Buse, Jessica Y. Islam, Jihad S. Obeid, Stephane Meystre, Steve Patterson, Misha Zemmel, Ron Grider, A. Pérez Martínez, Carlos Antônio do Nascimento Santos, Julian Solway, Ryan G. Chiu, Gerald B. Brown, Jia-Feng Cui, Sharon X. Liang, Kamil Khanipov, Jeremy Harper, Peter J. Embí, David Eichmann, Boyd M. Knosp, William B. Hillegass, Chunlei Wu, James R. Aaron, Darren W. Henderson, Muhammad Gul, Tamela Harper, Daniel R. Harris, Jeffery Talbert, Neil Bahroos, Steven M. Dubinett, Jomol Mathew ほか 69 名 - JAMA Network Open 2021 被引用: 247

  16. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

    著者: Daniel S. Ory, Elizabeth A. Ottinger, Nicole Y. Farhat, Kelly King, Xuntian Jiang, Lisa A. Weissfeld, Elizabeth Berry‐Kravis, Cristin Davidson, Simona Bianconi, Lee Ann Keener, Ravichandran Rao, Ariane Soldatos, Rohini Sidhu, Kimberly A. Walters, Xin Xu, Audrey Thurm, Beth Solomon, William J. Pavan, Bernardus N Machielse, Mark Kao, Steven A. Silber, John C. McKew, Carmen C. Brewer, Charles H. Vite, Steven U. Walkley, Christopher P. Austin, Forbes D. Porter - The Lancet 2017 被引用: 325

  17. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

    著者: Lesley A. Mathews Griner, Rajarshi Guha, Paul Shinn, Ryan M. Young, Jonathan M. Keller, Dongbo Liu, Ian S. Goldlust, Adam Yasgar, Crystal McKnight, Matthew B. Boxer, Damien Duveau, Jian‐kang Jiang, Sam Michael, Tim Mierzwa, Wenwei Huang, Martin J. Walsh, Bryan T. Mott, Paresma Patel, William Leister, David J. Maloney, Christopher A. LeClair, Ganesha Rai, Ajit Jadhav, Brian D. Peyser, Christopher P. Austin, Scott E. Martin, Anton Simeonov, Marc Ferrer, Louis M. Staudt, Craig J. Thomas - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 397

  18. Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization

    著者: Ruili Huang, Menghang Xia, Srilatha Sakamuru, Jinghua Zhao, Sampada A. Shahane, Matias S. Attene‐Ramos, Tongan Zhao, Christopher P. Austin, Anton Simeonov - Nature Communications 2016 被引用: 255

  19. Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective

    著者: Hugh Dawkins, Ruxandra Draghia‐Akli, Paul Lasko, Lilian Pek Lian Lau, Anneliene Hechtelt Jonker, Christine M. Cutillo, Ana Rath, Kym M. Boycott, Gareth Baynam, Hanns Lochmüller, Petra Kaufmann, Yann Le Cam, Virginie Hivert, Christopher P. Austin - Clinical and Translational Science 2017 被引用: 190

  20. From scientific discovery to treatments for rare diseases – the view from the National Center for Advancing Translational Sciences – Office of Rare Diseases Research

    著者: Petra Kaufmann, Anne Pariser, Christopher P. Austin - Orphanet Journal of Rare Diseases 2018 被引用: 157

  21. The Tox21 robotic platform for the assessment of environmental chemicals – from vision to reality

    著者: Matias S. Attene‐Ramos, Nicole Miller, Ruili Huang, Sam Michael, Misha Itkin, Robert J. Kavlock, Christopher P. Austin, Paul Shinn, Anton Simeonov, Raymond R. Tice, Menghang Xia - Drug Discovery Today 2013 被引用: 256

  22. High-throughput screening assays for the identification of chemical probes

    著者: James Inglese, Ronald L. Johnson, Anton Simeonov, Menghang Xia, Wei Zheng, Christopher P. Austin, Douglas S. Auld - Nature Chemical Biology 2007 被引用: 618

  23. The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics

    著者: Ruili Huang, Noel Southall, Yuhong Wang, Adam Yasgar, Paul Shinn, Ajit Jadhav, Ðắc-Trung Nguyễn, Christopher P. Austin - Science Translational Medicine 2011 被引用: 412

  24. Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia

    著者: Warren Fiskus, Nakhle S. Saba, Min Shen, Mondana Ghias, Jinyun Liu, Soumyasri Das Gupta, Lata Chauhan, Rekha Rao, Sumedha Gunewardena, Kevin Schorno, Christopher P. Austin, Kami J. Maddocks, John C. Byrd, Ari Melnick, Peng Huang, Adrian Wiestner, Kapil N. Bhalla - Cancer Research 2014 被引用: 246